Thrombin Generation before and after Cardiopulmonary Bypass in Pediatric Patients


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 17-000673
    Sponsor Protocol Number: 17-000673

About this study

The goal of this study is to survey the intraoperative dynamics of thrombin generation in pediatric patients ≤ 20 kg undergoing cardiac surgery.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Consent to participate in the study
  • Weight > 2 kg, ≤ 20 kg
  • No preoperative therapeutic anticoagulation exposure or antithrombin replacement

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Elena Ashikhmina, M.D., Ph.D.

Open for enrollment

Contact information:

Elena Ashikhmina M.D., Ph.D.


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer